Vous avez cherché: simparica (Anglais - Estonien)

how does simparica work?
kuidas simparica toimib?

simparica chewable tablets
simparica närimistabletid

why is simparica approved?
miks simparica heaks kiideti?

other information about simparica
muu teave simparica kohta

what are the risks associated with simparica?
millised riskid simparicaga kaasnevad?

what benefits of simparica have been shown in studies?
milles seisneb uuringute põhjal simparica kasulikkus?

it is not intended to provide practical advice on how to use simparica.
hindamisaruandes ei anta simparica kasutamise praktilisi nõuandeid.

the active substance in simparica, sarolaner acts as an ‘ectoparasiticide’.
simparica toimeaine sarolaneer toimib ektoparasititsiidina.

simparica was as effective as moxidectin and imidacloprid in eliminating live mites in skin scrapings.
nahakaabete põhjal oli simparica elus lestade hävitamisel sama efektiivne kui moksidektiin ja imidaklopriid.

for treatment of sarcoptic mange, simparica is given monthly for two consecutive months.
sarkoptoosi raviks tuleb simparicat manustada kord kuus kahel järjestikusel kuul.

simparica is a veterinary medicine used to treat tick, flea and sarcoptic mange infestations in dogs.
simparica on veterinaarravim, mida kasutatakse puukide, kirpude ja sarkoptoosi infestatsioonide tõrjeks koertel.

after simparica is given its activity against ticks and fleas lasts for for at least 5 weeks.
pärast simparica manustamist püsib puugi- ja kirbuvastane toime vähemalt 5 nädalat.

189 dogs were treated with simparica for three months whilst 96 dogs were given another medicine, spinosad.
189 koera raviti kolme kuu jooksul simparicaga ning 96 koerale manustati teist ravimit, spinosaadi.

the effectiveness of simparica against fleas was investigated in a field study in dogs infested with at least five live fleas.
väliuuringus uuriti simparica kirpudevastast tõhusust koertel, kellel esines vähemalt viis elus kirpu.

122 dogs were treated with simparica for three months whilst 59 dogs were treated with another medicine, fipronil, against ticks.
122 koera raviti kolme kuu jooksul simparicaga ning 59 koera raviti teise puugivastase ravimi, fiproniiliga.

for treatment of tick and flea infestations simparica should be given once every month throughout the flea and/or tick season for optimal control.
puugi- ja kirbuinfestatsioonide optimaalseks tõrjeks tuleb simparicat anda kord kuus kogu kirbu- ja/või puugihooaja vältel.

safety information has been included in the summary of product characteristics and the package leaflet for simparica, including the appropriate precautions to be followed by healthcare professionals and animal owners or keepers.
ravimi omaduste kokkuvõttesse ja pakendi infolehele lisati simparica ohutusteave, kus on ka tervishoiuspetsialistide ja loomaomanike või -pidajate võetavad meetmed.

the agency’s committee for medicinal products for veterinary use (cvmp) concluded that simparica’s benefits are greater than its risks and recommended that it be approved for use in the eu.
veterinaarravimite komitee järeldas, et simparica kasulikkus on suurem kui sellega kaasnevad riskid, ja soovitas ravimi kasutamise euroopa liidus heaks kiita.